Skip to content
Trial Eligibility
Menu

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain

NCT06361485

This study is recruiting at 4 US sites in 4 states, according to its ClinicalTrials.gov record last updated .

Summary

This is a Pilot Study that is an open label, prospective, non-controlled study in which the safety and feasibility of Wharton's Jelly (WJ) allograft will be evaluated in 100 participants suffering with low back pain.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Low Back Pain

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
20 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
R3 Stem Cell
Last updated on ClinicalTrials.gov
April 11, 2024

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arizona · 1

  • R3 Anti Aging Scottsdale · Scottsdale, AZ

California · 1

  • R3 Anti Aging Beverly Hills · Beverly Hills, CA

New York · 1

  • Scheer Medical Wellness · New York, NY

Texas · 1

  • Dr. Duc (Steve) Le, MD · Cleveland, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.